ADMA Biologics (ADMA) News Today $16.02 -0.61 (-3.67%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 Time Period ADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest UpdateADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) was the target of a significant increase in short interest in December. As of December 31st, there was short interest totalling 13,620,000 shares, an increase of 11.8% from the December 15th total of 12,180,000 shares. Based on an average daily trading volume, of 3,500,000 shares, the days-to-cover ratio is currently 3.9 days.January 18 at 4:39 AM | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by JPMorgan Chase & Co.JPMorgan Chase & Co. reduced its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 14.0% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 205,955 shares of the biotechnology company's stoJanuary 18 at 3:12 AM | marketbeat.comFY2024 EPS Estimates for ADMA Biologics Boosted by AnalystJanuary 17 at 1:53 AM | americanbankingnews.comADMA Biologics (NASDAQ:ADMA) Shares Down 8.8% - Here's WhyADMA Biologics (NASDAQ:ADMA) Trading Down 8.8% - Here's What HappenedJanuary 15 at 8:55 AM | marketbeat.comFY2024 EPS Estimates for ADMA Biologics Raised by AnalystADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) - Investment analysts at Cantor Fitzgerald raised their FY2024 earnings estimates for ADMA Biologics in a research note issued on Tuesday, January 14th. Cantor Fitzgerald analyst K. Kluska now anticipates that the biotechnology company will post eaJanuary 15 at 6:42 AM | marketbeat.comAdma Biologics reports preliminary FY24 revenue $417M-$425M, consensus $423.19MJanuary 14, 2025 | markets.businessinsider.comADMA Biologics Raises Full-year Revenue OutlookJanuary 13, 2025 | markets.businessinsider.comADMA Biologics (NASDAQ:ADMA) Trading Down 8.8% - What's Next?ADMA Biologics (NASDAQ:ADMA) Shares Down 8.8% - Time to Sell?January 13, 2025 | marketbeat.comEWG Elevate Inc. Makes New $480,000 Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)EWG Elevate Inc. bought a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 28,000 shares of the biotechnology company'sJanuary 13, 2025 | marketbeat.comADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business UpdateJanuary 13, 2025 | markets.businessinsider.comIs ADMA Biologics, Inc. (ADMA) the Best Growth Stock to Buy Now Under $25?January 9, 2025 | insidermonkey.comHow Is The Market Feeling About ADMA Biologics?January 1, 2025 | benzinga.comWhy Is ADMA Biologics, Inc. (ADMA) Among the Best Multibagger Stocks to Buy Right Now?January 1, 2025 | msn.comTop 5 best performing small-cap US stocks in 2024December 30, 2024 | msn.comStocks Showing Rising Market Leadership: Arcellx Earns 82 RS RatingDecember 27, 2024 | msn.comPrincipal Financial Group Inc. Acquires 1,059,394 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Principal Financial Group Inc. raised its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 785.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,194,221 shares of the biotechnology company's stock after buying an additiDecember 26, 2024 | marketbeat.comCarillon Chartwell Small Cap Growth Fund Q3 2024 CommentaryDecember 25, 2024 | seekingalpha.comTidal Investments LLC Lowers Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Tidal Investments LLC decreased its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 46.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,334 shares of the biotechnology company's stock aDecember 21, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Here's WhyADMA Biologics (NASDAQ:ADMA) Shares Gap Down - Should You Sell?December 20, 2024 | marketbeat.comADMA Biologics Announces Partial Paydown of Senior Term Loan Credit FacilityDecember 20, 2024 | globenewswire.comTeachers Retirement System of The State of Kentucky Invests $1.05 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Teachers Retirement System of The State of Kentucky acquired a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 52,392 shares of the biotechnology company'December 19, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Acquired by Geode Capital Management LLCGeode Capital Management LLC lifted its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 2.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 5,381,985 shares of the biotechnology company's stock after purchasing an additionalDecember 19, 2024 | marketbeat.comWellington Management Group LLP Reduces Position in ADMA Biologics, Inc. (NASDAQ:ADMA)Wellington Management Group LLP trimmed its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 80.1% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 119,293 shares of the biotechnology company's sDecember 18, 2024 | marketbeat.comApogee Therapeutics Trying To Close In On Key Technical MeasureDecember 17, 2024 | msn.comBarclays PLC Acquires 347,692 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Barclays PLC lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 192.2% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 528,629 shares of the biotechnology company's stock after acquiring an additioDecember 17, 2024 | marketbeat.comLord Abbett & CO. LLC Invests $61.86 Million in ADMA Biologics, Inc. (NASDAQ:ADMA)Lord Abbett & CO. LLC purchased a new stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm purchased 3,094,457 shares of the biotechnology company's stock,December 15, 2024 | marketbeat.comNeo Ivy Capital Management Purchases Shares of 48,584 ADMA Biologics, Inc. (NASDAQ:ADMA)Neo Ivy Capital Management acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 48,584 shares of the biotechnology comDecember 12, 2024 | marketbeat.comState Street Corp Increases Stock Position in ADMA Biologics, Inc. (NASDAQ:ADMA)State Street Corp grew its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 61.4% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 13,004,993 shares of the biotechnology company's stock after buying an additiDecember 11, 2024 | marketbeat.comStocks With Rising Relative Strength: VaxcyteDecember 10, 2024 | msn.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Cuts Stake in ADMA Biologics, Inc. (NASDAQ:ADMA)UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lessened its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 4.9% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 509December 9, 2024 | marketbeat.comFmr LLC Grows Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Fmr LLC grew its stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 3.7% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 1,944,831 shares of the biotechnology company's stock after buying an additionaDecember 9, 2024 | marketbeat.comZacks Investment Management Purchases Shares of 288,009 ADMA Biologics, Inc. (NASDAQ:ADMA)Zacks Investment Management acquired a new position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 288,009 shares of the biotechnology company's stoDecember 8, 2024 | marketbeat.comVirtus Investment Advisers Inc. Sells 79,371 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Virtus Investment Advisers Inc. trimmed its holdings in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 50.5% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 77,897 shares of the biotechnDecember 6, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Sold by Two Sigma Advisers LPTwo Sigma Advisers LP cut its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 4.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 4,454,400 shares of the biotechnology company's stock after selling 200,200 sharDecember 6, 2024 | marketbeat.comVerition Fund Management LLC Raises Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Verition Fund Management LLC raised its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 1,198.1% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 145,985 shares of the biotechnology company'December 5, 2024 | marketbeat.comWalleye Capital LLC Acquires 25,442 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Walleye Capital LLC increased its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 52.9% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 73,568 shares of the biotechnolDecember 5, 2024 | marketbeat.comCerity Partners LLC Purchases 30,637 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Cerity Partners LLC lifted its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 151.4% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 50,878 shares of the biotechnologyDecember 5, 2024 | marketbeat.comMiura Global Management LLC Reduces Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA)Miura Global Management LLC reduced its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 86.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 40,000 shares of the biotechnology companyDecember 4, 2024 | marketbeat.comMizuho Securities Remains a Buy on ADMA Biologics (ADMA)December 3, 2024 | markets.businessinsider.comADMA Biologics: Capitalizing On A $20 Billion IG Market With ASCENIVDecember 2, 2024 | seekingalpha.comPDT Partners LLC Acquires Shares of 63,859 ADMA Biologics, Inc. (NASDAQ:ADMA)PDT Partners LLC acquired a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 63,859 shares of the biotechnology company's stock, valued at approDecember 2, 2024 | marketbeat.comCharles Schwab Investment Management Inc. Acquires 249,412 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Charles Schwab Investment Management Inc. raised its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 11.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 2,401,533 shares of the biotechnology company's stocDecember 2, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Short Interest Down 6.3% in NovemberADMA Biologics, Inc. (NASDAQ:ADMA - Get Free Report) was the recipient of a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 14,240,000 shares, a decrease of 6.3% from the October 31st total of 15,200,000 shares. Based on an average daily volume of 5,080,000 shares, the days-to-cover ratio is currently 2.8 days.December 2, 2024 | marketbeat.comBNP Paribas Financial Markets Buys 85,250 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)BNP Paribas Financial Markets increased its position in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 12.8% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 750,788 shares of the biotechnology company's stock after aDecember 1, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Shares Bought by Citigroup Inc.Citigroup Inc. grew its stake in ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 251.7% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 387,226 shares of the biotechnology company's stock after purchasiNovember 30, 2024 | marketbeat.comADMA Biologics (NASDAQ:ADMA) Stock Price Down 3.4% - Time to Sell?ADMA Biologics (NASDAQ:ADMA) Shares Down 3.4% - Here's WhyNovember 29, 2024 | marketbeat.comPublic Sector Pension Investment Board Makes New Investment in ADMA Biologics, Inc. (NASDAQ:ADMA)Public Sector Pension Investment Board purchased a new stake in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 494,500 shares ofNovember 29, 2024 | marketbeat.comFORA Capital LLC Purchases New Shares in ADMA Biologics, Inc. (NASDAQ:ADMA)FORA Capital LLC purchased a new position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 41,547 shares of the biotechnology company's stock, valuNovember 29, 2024 | marketbeat.comADMA Biologics, Inc. (NASDAQ:ADMA) Stock Position Lifted by Healthcare of Ontario Pension Plan Trust FundHealthcare of Ontario Pension Plan Trust Fund grew its position in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 13.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 658,900 shares of theNovember 29, 2024 | marketbeat.comBank of Montreal Can Acquires 489,320 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA)Bank of Montreal Can lifted its holdings in shares of ADMA Biologics, Inc. (NASDAQ:ADMA - Free Report) by 30.6% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,086,322 shares of the bioNovember 29, 2024 | marketbeat.com Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address ADMA Media Mentions By Week ADMA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADMA News Sentiment▼0.420.64▲Average Medical News Sentiment ADMA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADMA Articles This Week▼157▲ADMA Articles Average Week Get ADMA Biologics News Delivered to You Automatically Sign up to receive the latest news and ratings for ADMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies GMAB News VTRS News ITCI News SMMT News MRNA News RDY News CTLT News SRPT News QGEN News PCVX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADMA) was last updated on 1/18/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredHOTTEST TRADER IN AMERICA 🔥🔥🔥Ready for a rocket ride this weekend? After alerting his readers to a tiny $2 stock called Bright Minds Bio...Timothy Sykes | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredBitcoin to $200K?Newsweek recently asked several analysts whether they think Bitcoin will hit $200,000 by the end of 2025. T...Stansberry Research | SponsoredElon's "Final Move" Could Send This Stock SoaringWhenever Elon Musk starts a new venture... Early investors get the opportunity to become millionaires... ...Behind the Markets | SponsoredThe Biggest Money-Making Idea in My 43 Years in the Stock MarketBillionaires and top investors - including the late great Charlie Munger - and many more names you would recog...The Oxford Club | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ADMA Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ADMA Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADMA Stock Alerts